These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 29328782

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Inhibitors of Cytotoxic T Lymphocyte Antigen 4 and Programmed Death 1/Programmed Death 1 Ligand for Metastatic Melanoma, Dual Versus Monotherapy-Summary of Advances and Future Directions for Studying These Drugs.
    Loo K, Daud AI.
    Cancer J; 2017; 23(1):3-9. PubMed ID: 28114249
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma.
    Maurice C, Schneider R, Kiehl TR, Bavi P, Roehrl MH, Mason WP, Hogg D.
    Cancer Immunol Res; 2015 Dec; 3(12):1299-302. PubMed ID: 26419960
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Advances in immunotherapy for metastatic melanoma].
    Oláh J.
    Magy Onkol; 2017 Jun 06; 61(2):132-136. PubMed ID: 28585614
    [Abstract] [Full Text] [Related]

  • 28. Cancer immunology and melanoma immunotherapy.
    Linck RDM, Costa RLP, Garicochea B.
    An Bras Dermatol; 2017 Jun 06; 92(6):830-835. PubMed ID: 29364441
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials.
    Yun S, Vincelette ND, Green MR, Wahner Hendrickson AE, Abraham I.
    Cancer Med; 2016 Jul 06; 5(7):1481-91. PubMed ID: 27167347
    [Abstract] [Full Text] [Related]

  • 34. Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma.
    Perier-Muzet M, Gatt E, Péron J, Falandry C, Amini-Adlé M, Thomas L, Dalle S, Boespflug A.
    JAMA Dermatol; 2018 Jan 01; 154(1):82-87. PubMed ID: 29214290
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma.
    Reddy SB, Possick JD, Kluger HM, Galan A, Han D.
    J Immunother; 2017 Oct 01; 40(8):307-311. PubMed ID: 28737620
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.